Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Seamless Phase II/III, Observer-blind, Multi-centre, Randomized Clinical Trial to Evaluate Immunogenicity and Safety of BBV87, an Inactivated Chikungunya Virus Vaccine in Healthy Subjects 12-65 Years of Age.

NCT07555392 is registered in ClinicalTrials.gov with Bharat Biotech International Limited as lead sponsor.

NCT NCT07555392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07555392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Seamless Phase II/III, Observer-blind, Multi-centre, Randomized Clinical Trial to Evaluate Immunogenicity and Safety of BBV87, an Inactivated Chikungunya Virus Vaccine in Healthy Subjects 12-65 Years of Age.
Lead sponsor
Bharat Biotech International Limited
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 20, 2026
Completion date
August 30, 2027
Enrollment
1,000 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

active immunisation for chikungunya virus infection